Ginkgo BioworksDNA

紐約證券 · USD
7.71
-0.14
(-1.78%)
收盤 05/16 03:59 (UTC+8)
盤後 
7.71 
7.71 
(0.00%)
05/16 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.35
  • 0.38
  • 0.56
  • 0.89
  • 0.44
  • 0.48
  • 0.50
  • 0.39
  • 0.33
  • 0.19
icon
  • -37.30
  • 9.18
  • 48.13
  • 58.43
  • -50.76
  • 10.20
  • 2.66
  • -21.71
  • -14.01
  • -41.69
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
營業收入淨額
19,474
33,396
38,837
49,604
48,318
43,847
89,046
56,206
37,944
34,755
營業成本
3,0987,30112,80214,82212,0479,62212,00313,7219,2026,611
營業毛利
16,376
26,095
26,035
34,782
36,271
34,225
77,043
42,485
28,742
28,144
營業費用
87,75096,847116,052100,323125,239----206,261
研發費用
49,92050,12769,35353,37070,92376,37777,006134,221136,457117,038
推銷及管理費用
37,83046,01444,95443,27949,04357,29752,29266,28570,28789,223
非經常性項目費用
-7061,7453,6745,2734,1572,94964,924--
其他營業費用
----------
營業利益
-71,374
-70,046
-90,017
-65,541
-88,968
-103,606
-55,204
-222,945
-178,002
-178,117
其他收入及費用
--10,6429,2634,958-1,901-4,159-1,5745,95412,122-32,563
利息費用
-----94---93
稅前純益
-76,139
-81,394
-80,754
-60,583
-90,869
-107,859
-56,778
-216,991
-165,880
-211,892
所得稅
-80-6431-28388-325-37519031-198
稅後純益
-82,587
-80,751
-80,755
-60,300
-90,957
-107,534
-56,403
-217,181
-165,911
-211,694
基本每股稅後盈餘(元)
-1.39-1.41-1.45-1.10-1.68-2.00-1.08-0.11-0.08-
稀釋每股稅後盈餘(元)
-1.39-1.42-1.45-1.09-1.68-1.96-1.02-0.11-0.08-0.11
基本平均股數(千股)
59563.0057098.0055633.0054858.0054241.0053814.0052240.002054801.002004458.00-
稀釋平均股數(千股)
59563.0057098.0055633.0054858.0054241.0053814.0052246.002055023.002005334.00-
還原基本每股稅後盈餘(元)
-1.39-1.41-1.45-1.10-1.68-2.00-1.08-4.23-3.31-
還原稀釋每股稅後盈餘(元)
-1.39-1.42-1.45-1.09-1.68-1.96-1.02-4.24-3.32-4.28
還原基本平均股數(千股)
59,56357,09855,63354,85854,24153,81452,24051,37050,111-
還原稀釋平均股數(千股)
59,56357,09855,63354,85854,24153,81452,24651,37550,133-
EBITDA(千元)
-69,868-68,619-69,088-44,790-75,503-92,113-39,609-199,661-153,011-197,915

大家都在看

HOT